![How to Scale Your GLP-1 Program with Home Health Testing](https://cdn.prod.website-files.com/62855c89a1682c055ae12077/664cfb5be3fbf914c77ac88e_Blog%20Hero%20Images%20(12).jpg)
Share
Digital Health
How to Scale Your GLP-1 Program with Home Health Testing
Ash Team
Digital health companies that want to scale GLP-1 programs require innovative solutions to ensure patient adherence and improve health outcomes. Home health testing allows patients to collect and submit their own blood samples from home, which empowers digital health companies to better manage their care. We will explore how home health testing works, its benefits for GLP-1 programs, and how digital health companies can generate revenue through these programs.
What is home health testing?
Home health testing lets patients collect their own health data, such as blood samples, from the comfort of their homes. One common method used in home health testing is dried blood spot cards, which requires patients to collect a small sample of capillary blood through a finger prick. The blood is then blotted onto a special filter paper on a test card. Once the blood sample dries, patients mail the test card to a laboratory, where technicians analyze it for specific health markers.
Home health testing kits typically include all necessary components for sample collection, such as a dried blood spot collection card, alcohol pads, gauze pads, single-use lancets, bandages, and a return pouch. This method is used for a variety of health screenings, including tests for HIV, Hepatitis B and C, syphilis, and other blood-borne diseases. It provides a convenient and efficient way for patients to monitor their health without visiting a healthcare facility.
How can digital health companies generate revenue from GLP-1 receptor agonist programs?
Digital health companies can generate revenue from GLP-1 receptor agonist programs through a variety of business models and strategies.
1. Subscription Services: Companies offer subscription-based programs for chronic disease management, including diabetes and obesity, where GLP-1 receptor agonists are often prescribed. These programs typically include access to digital tools, personalized coaching, and continuous monitoring.
2. Partnerships with Pharmaceutical Companies: Digital health companies develop companion apps that help patients manage their GLP-1 therapies more effectively. Pharmaceutical companies may partner with these digital health firms to enhance patient adherence and outcomes, often providing financial incentives or funding for these digital solutions.
Read more about remote medication adherence for GLP-1 drugs.
3. Telehealth Services: Digital health platforms offer telehealth services where patients can consult with healthcare providers to discuss their GLP-1 treatment plans. Fees for these virtual consultations provide another revenue stream. Offering a comprehensive care model that includes medication management, lifestyle coaching, and regular virtual check-ins can attract more patients willing to pay for a holistic approach to their health.
4. Health Insurance Partnerships: Insurers may reimburse digital health companies for providing remote monitoring and management services for patients on GLP-1 therapies. This could include value-based care agreements where the digital health company is compensated based on patient outcomes and cost savings achieved through improved management of GLP-1 therapies.
How can digital health companies use home health testing to manage GLP-1 programs?
Digital health companies can effectively manage GLP-1 therapies by leveraging home health testing to monitor key health markers such as BUN, creatinine, cholesterol levels, TSH, and HbA1c. These remote diagnostics help track patient responses to GLP-1 therapy, ensuring adherence to prescribed dosages and schedules, which is crucial for sustained weight loss. With at-home testing kits, companies can reduce the high discontinuation rates of GLP-1 therapies, as patients receive regular health updates and personalized care, keeping them engaged and committed to their treatment plans.
Additionally, combining GLP-1 therapy with lifestyle changes can significantly enhance weight loss outcomes. Remote health testing allows providers to monitor progress and adjust treatment plans in real-time, supporting patients' lifestyle changes and achieving better long-term results. This approach also helps in weaning patients off GLP-1 therapy once health targets are reached, reducing overall costs.
What are the benefits of home health testing for GLP-1s?
1. Convenience and Accessibility: Home health testing offers unparalleled convenience for patients. By allowing them to conduct medication adherence tests from the comfort of their homes, digital health companies reduce the need for in-person visits, thus saving time and resources for both patients and providers. This is particularly beneficial for those with mobility issues or those living in remote areas.
2. Improved Patient Compliance: When patients can easily test their HbA1c or other relevant biomarkers at home, they are more likely to comply with testing schedules. This continuous monitoring can lead to better disease management and more timely adjustments in GLP-1 therapy.
3. Enhanced Data Collection: With the advent of digital health technologies, home health testing can seamlessly integrate with electronic health records (EHR). This ensures that healthcare providers have real-time access to patient data, enabling more informed and proactive decision-making.
Partner with Ash Wellness for home health testing
Ash Wellness offers white-labeled kitting to help providers and organizations ensure medication adherence through home health testing. Clients can customize kit inserts or postcards with their branding, instructions, contact info, and QR codes for instructional videos. Additionally, general health and wellness resources can be included. These personalized kits, along with secure Patient Portal access, provide a seamless and branded experience for patients.
Schedule a time to chat with Ash Wellness.
Conclusion for GLP-1s and home health testing
Scaling a GLP-1 program with home health testing is a strategic approach to improve patient outcomes, enhance adherence, and reduce costs. Digital health companies can offer patients a convenient, efficient, and effective way to monitor their health and achieve their weight loss goals. This innovative approach ensures that both patients and providers benefit from the advantages of home health testing, leading to a more successful and sustainable GLP-1 program.
Ready to partner
with us?
Switch on at-home diagnostics today for your business or organization.